Abstract
In 1973 Bertino and co-workers [3] reviewed the chemotherapy of head and neck cancer. They concluded that “several agents are effective in the treatment of epidermoid cancers of the head and neck. The time is ripe for the development of effective drug combinations and programs utilizing chemotherapy, radiation therapy, and surgery in the treatment of these difficult neoplasms.” During the six years that have elapsed since those words were written, oncologists have been working busily along these very lines. In doing so, they have been spurred on by several factors: a resurgence of interest in methotrexate, particularly in high dose with leucovorin rescue; the identification of cis-diammine-dichloroplatinum (II) as an agent with significant activity in these tumors; and, perhaps most important, the climate of general optimism surrounding the combined-modality approach to human solid tumors. In this review we shall examine the general directions of systemic drug therapy for epidermoid carcinoma of the head and neck (ECHN) in the United States over the past few years. We shall not deal with intra-arterial chemotherapy or with the combination of single drugs and radiotherapy, both of which have been reviewed in detail elsewhere [3, 9, 20, 27].
Supported in part by NIH grants CA-08748 and CA-08526
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amer M, Izbicki R, Al-Sarraf M (1978) Combination of high-dose cis-platinum, Oncovin, and bleomycin in treatment of patients with advanced head and neck cancer. Proc Am Soc Clin Oncol 19:312
Baker L, Al-Sarraf M (1979) Comparative trial of cisplatinum, Oncovin, and bleomycin versus methotrexate in patients with advanced epidermoid carcinoma of the head and neck. Proc Am Assoc Cancer Res 20:202
Bertino JR, Mosher MB, Deconti RC (1973) Chemotherapy of cancer of the head and neck. Cancer 31:1141–1149
Bianco A, Taylor SG IV, Reich S, Merrill JM, Dewys WD (1979) Combination chemotherapy pilot studies in head and neck squamous cell cancer. Cancer Treat Rep 63:158–159
Bonomi PD, Slayton RE, Wolter J (1978) Phase II trial of adriamycin and cis-dichlorodiammineplatinum (II) in squamous cell, ovarian, and testicular carcinomas. Cancer Treat Rep 62:1211–1213
Buechler M, Mukherji B, Chasin W, Nathanson L (1979) High-dose methotrexate with and without BCG therapy in advanced head and neck malignancy. Cancer 43:1095–1100
Capizzi RL, Deconti RC, Marsh JC, Bertino JR (1970) Methotrexate therapy of head and neck cancer: improvement in therapeutic index by use of leucovorin “rescue”. Cancer Res 30:1782–1788
Caradonna R, Paladine W, Goldstein J, Ruckdeschel J, Hillinger S, Horton J (1978) Combination chemotherapy with high-dose cis-diamminedichloroplatinum (II), methotrexate, and bleomycin for epidermoid carcinoma of the head and neck. Proc Am Soc Clin Oncol 19:401
Carter SK (1977) The chemotherapy of head and neck cancer. Semin Oncol 4:413–424
Chretien P, Lipson SD, Makuch R, Ketcham A (1979) Adjuvant methotrexate in operable head and neck squamous carcinoma: follow-up report of a feasibility trial. Abstract in Proceedings of the 25th Meeting, Society of Head and Neck Surgeons, Pittsburgh, Pa
Clifford P (1979) Synchronous multiple drug chemotherapy and radiotherapy in the treatment of advanced (stage III and IV) squamous cell carcinoma of the head and neck. Proc Am Assoc Cancer Res 20:83
Clifford P, O’Connor AD, Durden-Smith J, Hollis BA, Edwards W, Dalley VM (1978) Synchronous multiple drug chemotherapy and radiotherapy for advanced (stage III and IV) squamous carcinoma of the head and neck. Antibiot Chemother 24:60–72
Cortes EP, Amin VC, Attie J, Eisenbud L, Khafif R, Wolk D, Arel I, Sciubba J, Akbiyik N (1979) Combination of low-dose bleomycin followed by cyclophosphamide, methotrexate, and 5-fluroruracil for advanced head and neck cancer. Proc Am Soc Clin Oncol 20:259
Cortes EP, Shedd D, Albert DJ, Ohnuma T, Hreshchyshyn M (1972) Adriamycin and bleomycin in advanced cancer. Proc Am Assoc Cancer Res 13:86
Costanzi JJ, Loukas D, Gagliano R, Griffiths C, Barranco S (1976) Intravenous bleomycin infusion as a potential synchronizing agent in human disseminated malignancies: a preliminary report. Cancer 38:1503–1506
Deconti RC (1976) Phase III comparison of methotrexate with leucovorin versus methotrexate alone versus a combination of methotrexate plus leucovorin, cyclophosphamide, and cytosine arabinoside in head and neck cancer. Proc Am Soc Clin Oncol 17:248
Dowell KE, Armstrong DM, Aust JB, Cruz AB (1975) Systemic chemotherapy of advanced head and neck malignancies. Cancer 35:1116–1120
Elias EG, Chretien P, Monnard E, Khan T, Bouchelle W, Wiernik P, Lipson S, Hande K, Zentai T (1979) Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Cancer 43:1025–1031
Goldberg N, Chretien P, Elias EG, Hande K, Chabner B, Myers C (1977) Preoperative high-dose methotrexate - a well-tolerated regimen in head and neck cancer. Proc Am Soc Clin Oncol 18:292
Goldsmith MA, Carter SK (1975) The integration of chemotherapy into a combined modality appraoch to cancer therapy. V. Squamous cell cancer of the head and neck. Cancer Treat Rev 2:137–158
Holoye PY, Byers RM, Gard DA, Goepfert H, Guillamondequi O, Jesse R (1978) Combination chemotherapy of head and neck cancer. Cancer 42:1661–1669
Hong WK, Bhutani R, Shapshay S, Craft ML, Ucmakli A, Snow MN, Vaughan C, Strong S (1978) Induction chemotherapy of advanced unresectable head and neck cancer with cis-diamminedichloroplatinum (II) (DDP) and bleomycin. Proc Am Soc Clin Oncol 19:321
Hong WK, Shapshay SM, Bhutani R, Craft ML, Ucmakli A, Yamaguchi KT, Vaughan CW, Strong MS (to be published) Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion. Cancer
Isacoff WH, Eilber F, Tabbarah H, Klein P, Dollinger M, Lemkin S, Sheehy P, Cone L, Rosenbloom B, Sieger L, Block J (1978) Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue. Cancer Treat Rep 62:1295–1304
Jacobs C, Bertino J, Goffinet D, Fee W, Goode RL (1978) 24-hour infusion of cis-platinum in head and neck cancers. Cancer 42:2135–2140
Kaplan BH, Vogl SE, Chiuten D, Lanham R, Wollner D (1979) Chemotherapy of advanced cancer of the head and neck with methotrexate, bleomycin, and cis-diamminedichloroplatinum in combination. Proc Am Soc Clin Oncol 20: 384
Khandekar JD, Dewys WD (1978) Chemoimmunotherapy of head and neck cancer. Am J Surg 135:688–695
Khandekar J, Wolff A (1977) A clinical trial of high dose methotrexate with leucovorin “rescue” in advanced epidermoid carcinoma of the head and neck. Proc Am Soc Clin Oncol 18:281
Kirkwood JM, Ervin T, Pitman S, Miller D, Weichselbaum R, Canellos G (1979) Twice-weekly low-dose methotrexate-leucovorin versus weekly high-dose methotrexate-leucovorin for advanced squamous carcinoma of the head and neck. Proc Am Soc Clin Oncol 20:314
Kirkwood J, Miller D, Pitman S, Canellos G, Frei E (1978) Initial high-dose methotrexate-leucovorin in advanced squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 19:398
Krakoff IH, Cvitkovic E, Currie V, Yeh S, Lamonte C (1977) Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion. Cancer 40:2027–2037
Lefkowitz E, Papac R, Bertino J (1967) Head and neck cancer III. Toxicity of 24 h infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinoma. Cancer Chemother Rep 51:305–311
Leone L, Ohnuma T (1979) Combined high-dose methotrexate rescue, bleomycin, and cis-platinum for untreated stage III and localized stage IV for advanced squamous carcinoma of the head and neck. Proc Am Soc Clin Oncol 20: 374
Levitt M, Mosher MB, Deconti RC, Farber LR, Skeel RT, Marsh JC, Mitchell MS, Papac RJ, Thomas ED, Bertino JR (1973) Improved therapeutic index of methotrexate and leucovorin “rescue”. Cancer Res 33:1729–1734
Livingston RB, Einhorn LH, Bodey GP, Burgess MA, Freireich E, Gottlieb J (1975) COMB (Cyclophosphamide, Oncovin, methyl-CCNU, and bleomycin): A four-drug combination in solid tumors. Cancer 36:327–332
Livingston RB, Einhorn LH, Burgess MA, Gottlieb JA (1976) Sequential combination chemotherapy for advanced recurrent squamous carcinoma of the head and neck. Cancer Treat Rep 60:103–105
Lokich J, Frei E III (1974) Phase II study of concurrent methotrexate and bleomycin chemotherapy. Cancer Res 34:2240–2242
Merino OR, Lundberg RD, Fletcher GH (1977) An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40:145–151
Moseley HS, Sasaki T, McConnell DB, Merhoff G, Wilson WL, Grage TB, Weiss AJ, Fletcher WS (1976) A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma. J Surg Oncol 8:35–42
Mosher MB, Deconti RC, Bertino JR (1972) Bleomycin therapy in advanced Hodgkin’s disease and epidermoid cancers. Cancer 30:56–60
Murphy WK, Livingston RB, Gehan E, Bodey GP (1977) Sequential chemotherapy in the treatment of cancer of the head and neck. Proc Am Assoc Cancer Res 18:190
Ohnuma T, Biller H, Kopel S, Holland JF (1978) High-dose methotrexate and leucovorin in patients with head and neck cancer. Proc Am Soc Clin Oncol 19:350
Panettiere FJ, Lane M, Lehane D (1978) Effectiveness of a new outpatient program utilizing CACP in the chemotherapy of advanced epidermoid head and neck tumors. A SWOG study. Proc Am Soc Clin Oncol 19:410
Petrovich Z, Block J, Barton R, Casciato R, Hittle R, Rice D, Jose L (1979) Treatment of stage IV carcinoma of the head and neck with radiotherapy and chemotherapy and radiotherapy combination. Proc Am Soc Clin Oncol 20:422
Pitman SW, Frei E III (1977) Weekly methotrexate - calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin’s lymphoma. Cancer Treat Rep 61:695–701
Pitman S, Frei E III (1977) Weekly methotrexate-citrovorum with alkalinization: tumor response in a phase II study. Proc Am Assoc Cancer Res 18:124
Pitman SW, Miller D, Weichselbaum R (1978) Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high-dose methotrexate with leucovorin rescue. Laryngoscope 88:632–638
Pitman SW, Minor DR, Papac R, Knopf T, Lowenthal I, Nystrom S, Bertino JR (1979) Sequential methotrexate-leucovorin and cis-platinum in head and neck cancer. Proc Am Soc Clin Oncol 20:419
Presant CA, Kolhouse JF, Klahr C (1976) Adriamycin, l,3-bis(2-chlorethyl)-l-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adeno carcinoma of the breast and other tumors. Cancer 37:620–628
Presant C, Ratkin G, Klahr C (1977) Adriamycin, BCNU, and cyclophosphamide in head and neck cancer. Proc Am Soc Clin Oncol 18:281
Randolph VL, Vallejo A, Spiro RH, Shah J, Strong EW, Huvos A, Wittes RE (1978) Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin, and radiation therapy. Cancer 41:460–467
Randolph VL, Wittes RE (1978) Weekly administration of cis-diamminedichloroplatinum (II) without hydration or osmotic diuresis. Eur J Cancer 14:753–756
Ratkin GA, Brown C, Ogura J (1978) Combination chemotherapy in head and neck cancer. Proc Am Soc Clin Oncol 19:330
Richman SP, Livingston RB, Gutterman J, Suen J, Hersh E (1976) Chemotherapy vs chemoimmunotherapy of head and neck cancer. Report of a randomized study. Cancer Treat Rep 60:535–539
Sako K, Razack MS, Kalnins I (1978) Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum. Am J Surg 136:529–533
Salem P, Hall SW, Benjamin RS, Murphy WK, Wharton JT, Bodey GP (1978) Clinical phase I-II study of cis-dichlorodiammineplatinum (II) given by continuous IV infusion. Cancer Treat Rep 62:1553–1555
Seagren S, Byfield J, Nahum A, Bone R (1979) Concurrent cyclophosphamide, bleomycin, and ionizing radiation in advanced squamous carcinoma of the head and neck. Proc Am Soc Clin Oncol 20:324
Shapshay SM, Hong WK, Incze JS, Yamaguchi K, Bhutani R, Vaughan CW, Strong MS (1978) Histopathologic findings after cis-platinum-bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg 136:534–538
Silverberg IJ, Philips TL, Friedman MA, Fu KA (1978) A phase I study of radiotherapy and multidrug chemotherapy in advanced head and neck cancer. Proc Am Soc Clin Oncol 19:345
Smith BL, Franz JL, Mira JG, Gates GA, Sapp J, Cruz AB Jr (1979) Simultaneous combination radiotherapy and multidrug chemotherapy for Stage III and Stage IV squamous carcinoma of the head and neck. Proc Am Soc Clin Oncol 20:394
Tarpley JL, Chretien P, Alexander JC Jr, Hoye RC, Block J, Ketcham AS (1975) High-dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study andd clinical trial. Am J Surg 130:481–486
Taylor SG, Bytell D, Sisson G (1977) Methotrexate with leucovorin as an adjuvant to surgery and radiotherapy in locally advanced squamous carcinoma of the head and neck. Proc Am Soc Clin Oncol 18: 346
Turrisi AT, Rosenzweig M, Von Hoff D, Muggia F (1978) The role of bleomycin in the treatment of advanced head and neck cancer. In: Bleomycin: Current Status and New Developments. Academic Press, New York, NY, pp 151–163
Wittes RE, Brescia F, Young CW, Magill GB, Golbey RB, Krakoff IH (1975) Combination chemotherapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck. Oncology 32:202–207
Wittes RE, Cvitkovic E, Shah J, Gerold F, Strong EW (1977) Cis-dichlorodiammineplatinum (II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep 61:359–366
Wittes RE, Heller K, Randolph V, Howard J, Vallejo A, Farr H, Harrold C, Gerold F, Shah J, Spiro R, Strong EW (to be published) Platinum-based chemotherapy as initial treatment in advanced head and neck cancer. Cancer Treat Rep
Wittes RE, Spiro RH, Shah J, Gerold F, Koven B, Strong EW (1977) Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin. Med Pediatr Oncol 3:301–309
Woods RL, Tattersall MHN, Sullivan J (1979) A randomized study of three doses of methotrexate in patients with advanced squamous cell cancer of the head and neck. Proc Am Assoc Cancer Res 20:262
Yagoda A, Lippman A, Winn RJ, Schulman P, Cohen FB (1975) Combination chemotherapy with bleomycin and methotrexate in patients with advanced epidermoid carcinoma. Proc Am Assoc Cancer Res 16:247
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wittes, R.E. (1981). Combination Chemotherapy of Head and Neck Cancer in the United States. In: Carter, S.K., Sakurai, Y., Umezawa, H. (eds) New Drugs in Cancer Chemotherapy. Recent Results in Cancer Research, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81565-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-81565-2_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81567-6
Online ISBN: 978-3-642-81565-2
eBook Packages: Springer Book Archive